U.S. ex rel. Schutte v. SuperValu: Trial counsel to SuperValu and Albertsons in False Claims Act suit alleging that pharmacies misrepresented their usual and customary prices.
Holwill v. AbbVie: Representing AbbVie, its CEO, and its former CFO in securities fraud class action regarding sales and marketing of Humira.
California ex rel. Suarez v. AbbVie: Representing AbbVie in action brought by California Department of Insurance under the California Insurance Frauds Prevention Act regarding patient support services.
Obtained complete dismissal of three different False Claims Act suits alleging Anti-Kickback Statute violations in connection with patient support services. U.S. ex rel. Suarez v. AbbVie, 2019 WL 4749967 (N.D. Ill. Sept. 30, 2019); U.S. ex rel. LaFauci v. AbbVie, 2019 WL 1450791 (D.N.J. Apr. 2, 2019); U.S. ex rel. Miller v. AbbVie, No. 3:16-CV-2111-N, Dkt. No. 58 (N.D. Tex. Mar. 13, 2019).
Obtained complete dismissal of all claims against Clemens Family Corporation in antitrust conspiracy suit alleging an agreement among pork producers to reduce supply and exchange competitively sensitive information to raise pork prices to all users. In re Pork Antitrust Litig., 2019 WL 3752497 (D. Minn. Aug. 8, 2019).
Obtained complete dismissal of all claims brought against Calumet Specialty Products as seller of an oil refinery for injuries alleged to have occurred after its sale. Pickett v. Superior Refining Co., No. 2018-CV-238, Dkt. No. 193 (July 31, 2019).
Representing client in federal investigation involving alleged violations of the Bank Secrecy Act and Anti-Money Laundering regulations.
Represented medical device company in negotiations with the Food and Drug Administration regarding labeling of medical device product.
Counseled AbbVie in its $63 billion acquisition of Allergan.
Counseled major league sports team on negotiations with local government over pending regulations.
